Gene therapy Stories

Australian Stories

Gene therapy stories

Viral vector facility selects SYSPRO Cloud ERP for compliance

Australia's first viral vector manufacturing firm, VVMF, adopts SYSPRO Cloud ERP to enhance operations in advancing cell and gene therapies at Westmead Precinct.

By Melania Watson • 3 min read • Tue, 29th Apr 2025

EduTech

Honeywell tech powers Peter Mac's AUD $105m cell and gene therapy manufacturing facility

Honeywell supports Peter Mac's AUD $105M Melbourne facility, Australia's first to commercialise CAR T-cell therapies, with advanced building tech.

By Catherine Knowles • 3 min read • Fri, 6th Sep 2024

Global Stories

Gene therapy stories

Data Analytics

AI transforms cell & gene therapy manufacturing with real-time insights

AI-driven real-time monitoring in cell and gene therapy manufacturing cuts costs, improves quality, and speeds patient access to advanced treatments globally.

By Sean Mitchell • 5 min read • Wed, 24th Sep 2025

Health Technologies

Fuse Vectors secures USD $5.2m for gene therapy tech

Danish biotech firm Fuse Vectors has secured USD $5.2 million in pre-seed funding to advance its innovative cell-free gene therapy technology.

By Sean Mitchell • 4 min read • Wed, 26th Feb 2025

Health Technologies

Peptide APIs drive growth in targeted therapy market

The peptide Active Pharmaceutical Ingredient market is poised for significant growth, driven by demand for targeted therapies and advances in synthesis technology.

By Kaleah Salmon • 3 min read • Thu, 30th Jan 2025